ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4
ESE3/EHF是罗格列酮的一个潜在靶点,它通过下调CXCR4来抑制胰腺癌干细胞特性。
期刊:Gut
影响因子:25.8
doi:10.1136/gutjnl-2020-321952
Zhou, Tianxing; Liu, Jing; Xie, Yongjie; Yuan, Shuai; Guo, Yu; Bai, Weiwei; Zhao, Kaili; Jiang, Wenna; Wang, Hongwei; Wang, Haotian; Zhao, Tiansuo; Huang, Chongbiao; Gao, Song; Wang, Xiuchao; Yang, Shengyu; Hao, Jihui
细胞生物学
胰腺癌
发育与干细胞
肿瘤
干细胞
肿瘤免疫
CXCR4